Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Early Diagnosis and Early Treatment of Alzheimer's Disease Based on Senile Plaque Imaging

Authors not listed

Shanghai Mental Health Center · 2019

Abstract

The purpose of this study is based on the Flutemetamol-PET senile plaque imaging to investigate the peripheral blood biochemical and brain MRI imaging biomarkers and to research completely independent intellectual property rights neuropsychological test tool for the MCI due to AD. At the same time, the investigators will study the efficacy and safety of early treatment of MCI due to AD by Huperzine A in 52 weeks.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-08 MST

Cite this

APA
Anonymous. (2019). Early Diagnosis and Early Treatment of Alzheimer's Disease Based on Senile Plaque Imaging. <em>Shanghai Mental Health Center</em>. https://clinicaltrials.gov/study/NCT02931136
Vancouver
Anonymous. Early Diagnosis and Early Treatment of Alzheimer's Disease Based on Senile Plaque Imaging. Shanghai Mental Health Center. 2019.
BibTeX
@misc{anon2019EarlyD, title = {Early Diagnosis and Early Treatment of Alzheimer's Disease Based on Senile Plaque Imaging}, author = {Anonymous}, journal = {Shanghai Mental Health Center}, year = {2019}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings